Eden Research (LON:EDEN) Reaches New 1-Year Low – Should You Sell?

Eden Research plc (LON:EDENGet Free Report)’s share price hit a new 52-week low on Thursday . The company traded as low as GBX 3.50 ($0.05) and last traded at GBX 3.62 ($0.05), with a volume of 541569 shares traded. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The business has a fifty day simple moving average of GBX 3.94 and a 200-day simple moving average of GBX 4.21. The stock has a market capitalization of £19.32 million, a P/E ratio of -200.00 and a beta of 0.92. The company has a debt-to-equity ratio of 1.25, a quick ratio of 2.42 and a current ratio of 3.80.

About Eden Research

(Get Free Report)

Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names.

Further Reading

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.